Skip to main content
. 2018 Sep 22;7:100039. doi: 10.1016/j.vas.2018.09.003

Table 2.

Epidemiological, clinical, and pathological characteristics according to the histological classification of mixed tumors in bitches.

Variables Benign mixed tumor Carcinomasin mixed tumors Carcinosarcoma P value
Number of cases 162 (18%) 682 (75%) 60 (7%)
Time of development (days) 297.25 ± 420.13 367.8 ± 430.98 570.5 ± 599.47 0.034
Age 8.89 ± 2.69 9.68 ± 2.74 10.50 ± 2.76 <0.001
Breed
Pure 131 (84%) 502 (78.2%) 41 (70.7%) 0.860
Mixed 25 (16%) 140 (21.8%) 17 (29.3%)
Ovariohysterectomy
Yes 16 (26.2%) 87 (20.5%) 11 (26.2%) 0.453
No 45 (73.8%) 337 (79.5%) 31 (73.8%)
Pseudocyesis
Present 27 (55.1%) 124 (39.6%) 9 (32.1%) 0.075
Absent 22 (44.9%) 189 (60.4%) 19 (67.9%)
Estrous cycle
Regular 33 (71.7%) 243 (73.4%) 22 (68.8%) 0.838
Irregular 13 (28.3%) 88 (26.6%) 10 (31.3%)
Hormone administration
Yes 3 (6.8%) 23 (7.4%) 3 (9.4%) 0.907
No 41 (93.2%) 287 (92.6%) 29(90.6%)
Location
Cranial thoracic 7 (5.1%) 35 (6.0%) 4 (7.8%) 0.251
Caudal thoracic 20 (14.5%) 84 (14.5%) 1 (2.0%)
Cranial abdominal 15 (10.9%) 110 (19%) 11 (21.6%)
Caudal abdominal 44 (31.9%) 161 (27.8%) 15 (29.4%)
Inguinal 52 (37.7%) 189 (32.6%) 20 (39.2%)
Adherence
Absent 160 (98.8) 616 (91.4%) 47 (78.3%) <0.001
Present 2 (1.2%) 58 (8.6%) 13 (21.7%)
Ulceration
Absent 161 (99.4%) 646 (95.8%) 52 (86.7%) <0.001
Present 1 (0.6%) 28 (4.2%) 8 (13.3%)
Relapse and/or distant metastases
Absent 162 (100%) 646(95.8%) 44 (71.1%) <0.001
Present 0 28 (4.2%) 16(27.8%)
Size
T1< 3.0 cm 97 (76.4%) 328 (56.3%) 5 (10.4%) <0.001
T2 3.0–5.0 cm 18 (14.2%) 142 (24.4%) 11 (22.9%)
T3> 5.0 cm 12 (9.4%) 113 (19.4%) 32 (66.7%)
Clinical stage
I 97 (76.4%) 318 (54.5%) 3 (6%) <0.001
II 18 (14.2%) 132 (22.6%) 8 (16%)
III 12 (9.4%) 90 (15.4%) 24 (48%)
IV - 42 (7.2%) 13 (26%)
V - 2 (0.3%) 2 (4%)
Histological grade
I 59 (67%) 3 (17.7%) <0.001
II 26 (29.6%) 6 (35.3%)
III 3 (3.4%) 8 (47.1%)